Lipont Pharmaceuticals Inc. is a well-established and science-based drug development company. We have specialized on developing new therapeutics as well as commercializing generic drug products. Leveraging on its capabilities in research and development, Lipont has developed proprietary LD-ER technology for the purpose of releasing therapeutics at an extended period and optimal speed.
Research at Lipont includes the development of both generic and innovative pharmaceuticals. New generic products have been a critical component of Lipont's growth and have resulted in the development of substantial expertise in formulation development, synthetic and analytical chemistry
Lipont is also developing a non-invasive blood pressure continuous monitoring system which can continuously monitor the patient's blood pressure waveform in real time